Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMP-301 Interaction with Cocaine
NCT06648668Phase 1Completed
- Sponsor
- Tempero Bio
- Start
- Jan 2025
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in cocaine use disorder (CUD) comparing TMP-301 with Placebo (2 arms). Primary endpoints: Treatment-Emergent Adverse Events, Peak change from baseline of heart rate and 3 more. Started Jan 2025; status: completed.
02
Drugs
TMP-301
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT06648668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06648668.